S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q4 2024

RA Capital Management

Period: Q4 2024 Β· Filed: 2025-02-14
View on SEC EDGAR β†—
AUM
$7.51B
Total portfolio value
Positions
89
Reported securities
Top Holding
ASND
18.5% $1.39B
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2025-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S - ADR$1.39B18.53%$137.67$274.50+99.4%
18.5%
PCVXVAXCYTE INC$711.3M9.47%$81.86$58.39-28.7%
9.5%
JANXJANUX THERAPEUTICS INC$555.0M7.39%$53.54$15.54-71.0%
7.4%
RYTMRHYTHM PHARMACEUTICALS INC$340.6M4.53%$55.98$114.17+104.0%
4.5%
LEGNLEGEND BIOTECH CORP-ADR$244.3M3.25%$32.54$29.91-8.1%
3.3%
EWTXEDGEWISE THERAPEUTICS INC$237.9M3.17%$26.70$39.56+48.2%
3.2%
NAMSNEWAMSTERDAM PHARMA CO NV$227.3M3.03%$25.70$34.83+35.5%
3.0%
WVEWAVE LIFE SCIENCES LTD$225.2M3.00%$12.37$6.26-49.4%
3.0%
ACLXARCELLX INC$213.8M2.84%$76.69β€”
2.8%
RNAMAVIDITY BIOSCIENCES INC$183.2M2.44%β€”β€”
2.4%
SEPNSEPTERNA INC$160.2M2.13%$22.90$34.00+48.5%
2.1%
DYNDYNE THERAPEUTICS INC$150.3M2.00%$23.56$23.07-2.1%
2.0%
TYRATYRA BIOSCIENCES INC$147.9M1.97%$13.90$30.62+120.3%
2.0%
RXSTRXSIGHT INC$128.7M1.71%$34.38$5.61-83.7%
1.7%
BCAXBICARA THERAPEUTICS INC$121.2M1.61%$17.42$29.00+66.5%
1.6%
LENZLENZ THERAPEUTICS INC$120.6M1.61%$28.87$5.89-79.6%
1.6%
SPRYARS PHARMACEUTICALS INC$114.6M1.52%$10.55$8.56-18.9%
1.5%
ETNB89BIO INC$110.8M1.48%β€”β€”
1.5%
XBISPDR S&P BIOTECH ETF$110.6M1.47%$89.64$160.46+79.0%
1.5%
GERNGERON CORP$106.2M1.41%$3.54$1.36-61.6%
1.4%
ARTVARTIVA BIOTHERAPEUTICS INC$99.3M1.32%$10.08$9.61-4.7%
1.3%
AXSMAXSOME THERAPEUTICS INC$84.6M1.13%$84.61$244.31+188.8%
1.1%
VRNAVERONA PHARMA PLC - ADR$82.0M1.09%β€”β€”
1.1%
DAWNDAY ONE BIOPHARMACEUTICALS I$72.9M0.97%β€”β€”
1.0%
APGEAPOGEE THERAPEUTICS INC$71.1M0.95%$45.30$132.91+193.4%
0.9%
MLYSMINERALYS THERAPEUTICS INC$59.7M0.79%$12.31$27.69+124.9%
0.8%
PRAXPRAXIS PRECISION MEDICINES I$58.6M0.78%$76.96$318.52+313.9%
0.8%
CLYMCLIMB BIO INC$56.5M0.75%$1.80$12.90+616.7%
0.8%
RXRXRECURSION PHARMACEUTICALS-A$52.2M0.69%$6.76$3.80-43.8%
0.7%
TRMLTOURMALINE BIO INC$51.5M0.69%β€”β€”
0.7%

Quarter-on-Quarter Activity

Q4 2024 vs. Q3 2024

New Positions (8)

TickerIssuerNotionalSince Filing
SEPNSEPTERNA INC$160.2M+48.5%
XBISPDR S&P BIOTECH ETF$110.6M+79.0%
TXG10X GENOMICS INC-CLASS A$47.1M
KURAKURA ONCOLOGY INC$38.8M
ZLABZAI LAB LTD-ADR$33.9M
NRIXNURIX THERAPEUTICS INC$25.1M
EYPTEYEPOINT PHARMACEUTICALS INC$23.7M
CBLLCERIBELL INC$21.3M

Exited Positions (8)

TickerIssuerNotional
BIIBBIOGEN INC$229.6M
CGONCG ONCOLOGY INC$52.7M
ANROALTO NEUROSCIENCE INC$23.7M
NUVLNUVALENT INC-A$18.0M
TNYATENAYA THERAPEUTICS INC$13.5M
CRVOCERVOMED INC$11.9M
ADGMADAGIO MEDICAL HOLDINGS INC$3.4M
MGXMETAGENOMI INC$2.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
SCLXXXXXSCILEX HOLDING CO$0.2M+296.7%
TARAPROTARA THERAPEUTIC INC$14.5M+78.9%
VORXXXXVOR BIOPHARMA INC$28.1M+74.3%
CDTXCIDARA THERAPEUTICS INC$21.8M+55.4%
ACLXARCELLX INC$59.1M+50.5%
JANXJANUX THERAPEUTICS INC$138.6M+13.1%-71.0%
NAMSNEWAMSTERDAM PHARMA CO NV$93.5M+9.7%+35.5%
ASNDASCENDIS PHARMA A/S - ADR$-57.6M+4.1%+99.4%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
VRNAVERONA PHARMA PLC - ADR$-62.1M-64.7%
EVHEVOLENT HEALTH INC - A$-200.6M-58.0%
RGLSREGULUS THERAPEUTICS INC$-0.7M-56.1%
BCYCBICYCLE THERAPEUTICS PLC-ADR$-35.7M-51.5%
RXRXRECURSION PHARMACEUTICALS-A$-49.2M-49.8%-43.8%
BIOABIOAGE LABS INC$-38.4M-40.7%
ITOSITEOS THERAPEUTICS INC$-16.4M-34.3%
DAWNDAY ONE BIOPHARMACEUTICALS I$-36.7M-26.9%
← Back to Hedge Funds